Preoperative Low Prealbumin Is Associated With Recurrence in Patients With Stage II/III Gastric Cancer After Laparoscopic D2 Gastrectomy

被引:7
|
作者
Gao, Chun [1 ]
Zeng, Ci Dian Dan [1 ]
Tong, Yi Xin [1 ]
Zhu, Li [1 ]
Zhang, Sheng [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
gastric cancer; recurrence; risk factor; prealbumin; recurrence-free survival; cancer; PROGNOSTIC NUTRITIONAL INDEX; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; METASTASES; INDICATOR; SURVIVAL; COMPLICATIONS; CARCINOMA; JAPANESE; SURGERY;
D O I
10.3389/fsurg.2022.819514
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundPostoperative recurrence is associated with poor prognosis in patients with gastric cancer. This study aimed to explore predictive factors contributing to recurrence in patients with stage II/III gastric cancer after laparoscopic D2 gastrectomy. MethodsThis retrospective study was conducted at a single tertiary referral hospital. Patients diagnosed with gastric cancer who met the inclusion criteria were included in the study. The clinicopathological characteristics of the patients were collected. The patients were divided into recurrence and non-recurrence groups. The predictive factors were investigated using univariate and multivariate analyses. ResultsIn total, 462 patients were included. The incidence of recurrence was 26.4% (122/462) in all patients. The most common recurrence pattern was haematogenous recurrence. In the multivariate analysis, the independent predictive factors for recurrence were serum prealbumin level (p < 0.001), prognostic nutritional index (p = 0.001), carbohydrate antigen 19-9 (CA19-9) (p < 0.001), number of lymph node metastases (p < 0.001), signet-ring cell carcinoma (p = 0.001), tumor deposit (p = 0.001), and no/incomplete adjuvant chemotherapy (p < 0.001). ConclusionsOur findings revealed that nutritional status was an independent predictive factor for recurrence in patients with gastric cancer after D2 gastrectomy. We suggest that patients with risk factors for recurrence receive both nutritional support and intense surveillance.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Risk factors for early recurrence after radical gastrectomy followed by adjuvant chemotherapy for stage II or III gastric cancer: a multicenter, retrospective study
    Yagi, Shusuke
    Kumagai, Koshi
    Nunobe, Souya
    Ishizuka, Naoki
    Yamaguchi, Toshifumi
    Imai, Yoshiro
    Tsuda, Masahiro
    Haruta, Shusuke
    Fukunaga, Hiroki
    Yamada, Takanobu
    Goto, Masahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (04) : 403 - 415
  • [22] Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy
    Wu, Bin
    Li, Te
    Cai, Jian
    Xu, Yuejuan
    Zhao, Gang
    BMC CANCER, 2014, 14
  • [23] Impact of tumor regression grade on recurrence after preoperative chemoradiation and gastrectomy for gastric cancer
    Stark, Alexander P.
    Estrella, Jeannelyn S.
    Chiang, Yi-Ju
    Das, Prajnan
    Minsky, Bruce D.
    Blum Murphy, Mariela A.
    Ajani, Jaffer A.
    Mansfield, Paul
    Badgwell, Brian D.
    Ikoma, Naruhiko
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (03) : 422 - 432
  • [24] Laparoscopic Total Gastrectomy with D2 Lymphadenectomy for Advanced Gastric Cancer
    Lee, Ju-Hee
    Ahn, Sang-Hoon
    Park, Do Joong
    Kim, Hyung-Ho
    Lee, Hyuk-Joon
    Yang, Han-Kwang
    WORLD JOURNAL OF SURGERY, 2012, 36 (10) : 2394 - 2399
  • [25] Is D2 laparoscopic gastrectomy essential for elderly patients with advanced gastric cancer?
    Feng, Qingbo
    Zhang, Tao
    Xie, Ming
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (05) : 2703 - 2704
  • [26] Prognostic Significance of Preoperative Nutritional Assessment in Elderly Patients who Underwent Laparoscopic Gastrectomy for Stage I-III Gastric Cancer
    Uehara, Hideo
    Ota, Mitsuhiko
    Yamamoto, Manabu
    Nakanoko, Tomonori
    Shin, Yuki
    Shiokawa, Keiichi
    Fujimoto, Yoshiaki
    Nakashima, Yuichiro
    Sugiyama, Masahiko
    Onishi, Emi
    Shimagaki, Tomonari
    Mano, Yohei
    Sugimachi, Keishi
    Morita, Masaru
    Toh, Yasushi
    ANTICANCER RESEARCH, 2023, 43 (02) : 893 - 901
  • [27] Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
    Shitara, Kohei
    Chin, Keisho
    Yoshikawa, Takaki
    Katai, Hitoshi
    Terashima, Masanori
    Ito, Seiji
    Hirao, Motohiro
    Yoshida, Kazuhiro
    Oki, Eiji
    Sasako, Mitsuru
    Emi, Yasunori
    Tsujinaka, Toshimasa
    GASTRIC CANCER, 2017, 20 (01) : 175 - 181
  • [29] Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy
    Kano, Yosuke
    Ohashi, Manabu
    Muneoka, Yusuke
    Takahari, Daisuke
    Chin, Keisho
    Yamaguchi, Kensei
    Ida, Satoshi
    Kumagai, Koshi
    Makuuchi, Rie
    Sano, Takeshi
    Nunobe, Souya
    EJSO, 2021, 47 (12): : 3097 - 3104
  • [30] Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer
    Nishibeppu, Keiji
    Komatsu, Shuhei
    Ichikawa, Daisuke
    Imamura, Taisuke
    Kosuga, Toshiyuki
    Okamoto, Kazuma
    Konishi, Hirotaka
    Shiozaki, Atsushi
    Fujiwara, Hitoshi
    Otsuji, Eigo
    BMC CANCER, 2018, 18